# BioLife Solutions, Inc. (BLFS) FY2026 YTD Q2 P&L / Income Statement

- Company: BioLife Solutions, Inc. (BLFS)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001628280-26-054355
- Page: https://plicit.ai/financials/blfs/fy2026-ytd-q2-income-statement
- Chart image: https://plicit.ai/charts/blfs-fy2026-ytd-q2-income-statement-sankey.png

## Chart details: Revenue by Geography

Income statement for 2026-01-01 through 2026-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Revenue**: 55,966,000 US dollars
- **Cost of revenue**: 20,182,000 US dollars
- **Gross profit**: 35,784,000 US dollars
- **Operating expenses (calculated)**: 34,059,000 US dollars
- **Operating income (loss)**: 1,725,000 US dollars
- **Total other income, net**: 2,277,000 US dollars
- **Income (loss) before income tax (benefit) expense**: 4,002,000 US dollars
- **Income tax (benefit) expense**: negative 42,288,000 US dollars
- **Net income (loss)**: 46,290,000 US dollars
- **Other (calculated)**: 3,357,960 US dollars
- **UNITED STATES (calculated)**: 44,772,800 US dollars
- **Europe, Middle East, Africa (EMEA) (calculated)**: 7,835,240 US dollars
- **General and administrative**: 22,901,000 US dollars
- **Research and development**: 5,608,000 US dollars
- **IPR&D expense**: 0 US dollars
- **Intangible asset amortization**: 242,000 US dollars
- **Sales and marketing**: 5,308,000 US dollars
- **Loss from discontinued operations**: 0 US dollars. Reported below-tax contribution to net income.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.